Using flow cytometry and fluorescein-labelled lipopolysaccharide (LPS)
from Salmonella minnesota R595 (FITC-ReLPS), we studied the role of m
embrane proteins in the recognition of LPS by human polymorphonuclear
granulocytes (PMN) in the absence of serum. Treatment of PMN with tryp
sin, pronase E or proteinase K reduced both the binding of FITC-ReLPS
to PMN at 4 degrees and the response of PMN to LPS at 37 degrees, as m
easured by luminol-enhanced chemiluminescence. Neuraminidase treatment
enhanced both activities. Trypsin treatment of PMN after the binding
of FITC-ReLPS effectively reduced fluorescence when cells were kept at
40, while further incubation of FITC-ReLPS-labelled PMN at 37 degrees
rendered fluorescence insensible to trypsin. These results indicate a
protein structure of the LPS binding site, association of FITC-ReLPS
with the cell membrane at 4 degrees and subsequent internalization at
37 degrees. The binding of FITC-ReLPS was not inhibited by the anti-CD
14 monoclonal antibody (mAb) 3C10, which recognizes a functional epito
pe of CD14. Furthermore, binding of FITC-ReLPS was observed to PMN obt
ained from a patient with paroxysmal nocturnal haemoglobinuria who lac
ked membrane-bound CD14. Stimulation of PMN with tumour necrosis facto
r (TNF) or LPS enhanced the binding of FITC-ReLPS at 4 degrees. This w
as not observed after activation of PMN devoid of granules (cytoplasts
), indicating that the binding of LPS at the cell surface is enhanced
by mobilization of LPS-binding proteins from intracellular granules. T
hese studies provide evidence that LPS binding and activation of PMN i
nvolves protein structures at the cell surface different from CD14, an
d that granules constitute a pool of LPS-binding proteins that can be
translocated to the cell surface upon stimulation.